Unclassifiable interstitial lung disease: An unresolved diagnostic dilemma

Respirology Case Reports

Volumn 3, Issue 3, 2015, Pages 85-88

  Leung, Stefanie C ^a   Churg, Andrew M ^a   Leipsic, Jonathon A ^a   Levy, Robert D ^a   Wilcox, Pearce G ^a   Ryerson, Christopher J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diffuse lung disease; Idiopathic interstitial pneumonia; Interstitial lung disease; Unclassifiable interstitial lung disease

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; CREATINE KINASE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; MYCOPHENOLATE MOFETIL; PREDNISONE; RHEUMATOID FACTOR;

ADULT; ARTICLE; BACTERIUM CULTURE; BRONCHOALVEOLAR LAVAGE FLUID; CASE REPORT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC RADIOLOGIST; DRUG OVERDOSE; DYSPNEA; FATIGUE; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LOW DRUG DOSE; LUNG BIOPSY; LUNG PARENCHYMA; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; OXYGEN SATURATION; PATHOLOGIST; PATHOLOGY; POLYMERASE CHAIN REACTION; SEROLOGY; SPIROMETRY;

EID: 85006925465     PISSN: None     EISSN: 20513380     Source Type: Journal    
DOI: 10.1002/rcr2.112     Document Type: Article

References (5)

1. Travis WD, Costabel U, Hansell DM, et al. 2013. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 188: 733-748.
2. Skolnik K, and Ryerson CJ. 2015. Unclassifiable interstitial lung disease: a review. Respirology. doi: 10.1111/resp.12568.
3. Troy L, Glaspole I, Goh N, et al. 2014. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir. J. 43: 1529-1530.
4. Ryerson CJ, Urbania TH, Richeldi L, et al. 2013. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir. J. 42: 750-757.
5. Raghu G, Collard HR, Egan JJ, et al. 2011. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183: 788-824.